en · de · es · fr · pt
sr9009-notes.peptides6088.com › News › Background And Receptor Mechanism — Research Overview

Background And Receptor Mechanism — Research Overview

By Editorial Desk · published 2025-07-04 · last reviewed 2025-07-21 · News

A practical reference on nuclear receptor: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

This page was last updated on 2025-07-21 and is reviewed periodically as new material appears.

Background and Receptor Mechanism

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ, also called NR1D1 and NR1D2. These receptors help regulate circadian rhythms and metabolic gene programs. The compound was developed for laboratory research, not as an approved therapeutic. Its identity is distinct from steroid hormones and selective androgen receptor modulators. Scientific interest centers on how REV-ERB activation changes gene expression in cells and animal models.

At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.

Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.

Analytical Detection and Stability

Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.

Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.

Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.

Sr9009 at a glance

PropertyValueNotes
Chemical classSynthetic small moleculeStudied as a REV-ERB agonist
Molecular formulaC20H24ClN3O4SReported for the neutral compound
AppearanceOff-white to pale yellow solidTypical research-grade material
SolubilitySparingly soluble in waterSoluble in solvents such as DMSO
Common synonymsSR9009; StenabolicStenabolic is an informal alias

Handling Storage and Quality Control

Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.

Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.

Related pages on this site

Reference notes

Example of comparing and determining the % difference between two nucleotide sequences AATCCGCTAG AAACCCTTAG Given the two 10-nucleotide sequences, line them up and compare the differences between them. Calculate the percent difference by taking the number of differences between the DNA bases divided by the total number of nucleotides. In this case there are three differences in the 10 nucleotide sequence. Thus there is a 30% difference.

In July 2009, there were a series of coordinated denial of service attacks against major government, news media, and financial websites in South Korea and the United States. While many thought the attack was directed by North Korea, one researcher traced the attacks to the United Kingdom. Security researcher Chris Kubecka presented evidence multiple European Union and United Kingdom companies unwittingly helped attack South Korea due to a W32.Dozer infections, malware used in part of the attack. Some of the companies used in the attack were partially owned by several governments, further complicating cyber attribution. In July 2011, the South Korean company SK Communications was hacked, resulting in the theft of the personal details (including names, phone numbers, home and email addresses and resident registration numbers) of up to 35 million people. A trojaned software update was used to gain access to the SK Communications network. Links exist between this hack and other malicious activity and it is believed to be part of a broader, concerted hacking effort. With ongoing tensions on the Korean Peninsula, South Korea's defense ministry stated that South Korea was going to improve cyber-defense strategies in hopes of preparing itself from possible cyber attacks. In March 2013, South Korea's major banks – Shinhan Bank, Woori Bank and NongHyup Bank – as well as many broadcasting stations – KBS, YTN and MBC – were hacked and more than 30,000 computers were affected; it is one of the biggest attacks South Korea has faced in years.

RCH=CH2 + H2 + CO → RCH2−CH2CHO Rh-based hydroformylation underpins the industrial production of products as diverse as detergents, fragrances, and some drugs. Rhodium based catalysts have 1000 to 10000 times higher activity for hydroformylation than cheaper cobalt carbonyl-based catalysts, allowing reactions at lower temperatures and pressures. Rhodium is also known to catalyze many reactions involving hydrogen gas and hydrosilanes. These include hydrogenations and hydrosilylations of alkenes. Rhodium metal, but not rhodium complexes, catalyzes the hydrogenation of benzene to cyclohexane.

Sources: en.wikipedia.org

Reference notes

The Kulturkampf had reinforced the Catholic character of the Centre Party, but even during it Ludwig Windthorst had defended the party against Bismarck's accusation of being a "denominational party" in describing the Centre as "a political party with a comprehensive political programme and open to anyone, who accepts it". However, few Protestants took up this offer and the Centre remained, by the composition of its members, politicians and voters, an essentially Catholic party. Loyal to the Pope in church matters, the Centre party steered a course independent of the Holy See on secular matters. This became apparent in the "septennat dispute" of 1886. Since the Centre Party rejected Bismarck's military budget, the Chancellor negotiated with the Holy See and promised to abolish some Kulturkampf-related laws and to support the Pope in the Roman question, if the Vatican persuaded the Centre Party to accept his bill. Despite this agreement, the Centre Party rejected the budget and Bismarck called new elections. He also published the letters with the Vatican, intending to drive a wedge between Catholic voters loyal to the Pope and the Centre Party with the slogan: "The Pope against the Centre!" Windhorst managed to avert this by reaffirming the Party's autonomy, which the Pope had accepted, and by interpreting the published letters as expressions of papal confidence in the party.

=== Complex flavoenzymes === Glutamate synthase catalyzes the conversion of 2-oxoglutarate into L-glutamate with L-glutamine serving as the nitrogen source for the reaction. All glutamate syntheses are iron-sulfur flavoproteins containing an iron-sulfur cluster and FMN. The three classes of glutamate syntheses are categorized based on their sequences and biochemical properties. Even though there are three classes of this enzyme, it is believed that they all operate through the same mechanism, only differing by what first reduces the FMN. The enzyme produces two glutamate molecules: one by the hydrolysis of glutamine (forming glutamate and ammonia), and the second by the ammonia produced from the first reaction attacking 2-oxoglutarate, which is reduced by FMN to glutamate.

Once mRNA decoding is complete, the aminoacyl-tRNA is bound in the A/A site and is ready for the next peptide bond to be formed to its attached amino acid. The peptidyl-tRNA, which transfers the growing polypeptide to the aminoacyl-tRNA bound in the A/A site, is bound in the P/P site. Once the peptide bond is formed, the tRNA in the P/P site is acylated, or has a free 3' end, and the tRNA in the A/A site dissociates the growing polypeptide chain. To allow for the next elongation cycle, the tRNAs then move through hybrid A/P and P/E binding sites, before completing the cycle and residing in the P/P and E/E sites. Once the A/A and P/P tRNAs have moved to the P/P and E/E sites, the mRNA has also moved over by one codon and the A/T site is vacant, ready for the next round of mRNA decoding. The tRNA bound in the E/E site then leaves the ribosome. The P/I site is actually the first to bind to aminoacyl tRNA, which is delivered by an initiation factor called IF2 in bacteria. However, the existence of the P/I site in eukaryotic or archaeal ribosomes has not yet been confirmed. The P-site protein L27 has been determined by affinity labeling by E. Collatz and A. P. Czernilofsky (FEBS Lett., Vol. 63, pp. 283–286, 1976).

Sources: en.wikipedia.org

Reference notes

Plant cells have cell walls composed of cellulose, hemicelluloses, and pectin that are constructed outside the cell membrane. In sclerenchyma tissue lignin is secreted to form a secondary wall inside the primary cell wall. Cutin is secreted outside the primary cell wall and into the outer layers of the secondary cell wall of the epidermal cells of leaves, stems and other above-ground organs to form the plant cuticle. Cell walls perform many essential functions, they provide shape to form the tissue and organs of the plant, and play an important role in intercellular communication and plant-microbe interactions. Specialized cell-to-cell communication pathways known as plasmodesmata, occur in the form of pores in the primary cell wall through which the cell membrane and endoplasmic reticulum of adjacent cells are continuous. Organelles in plant cells, include pigment-containing plastids, especially chloroplasts that contain chlorophyll (also found in algae), large water-storage vacuoles, and two types of peroxisome. Chloroplasts capture the sun's energy to make carbohydrates through photosynthesis. Chromoplasts contain fat-soluble carotenoid pigments such as orange carotene and yellow xanthophylls which helps in synthesis and storage. Leucoplasts are non-pigmented plastids and helps in storage of nutrients. Plastids divide by binary fission. The vacuoles are larger than those in animal cells, and their membrane transports ions against concentration gradients. One type of peroxisome is in the leaves where it takes part in photorespiration.

Chloroplast – Cell Centered Database Clegg MT, Gaut BS, Learn GH, Morton BR (July 1994). "Rates and patterns of chloroplast DNA evolution". Proceedings of the National Academy of Sciences of the United States of America. 91 (15): 6795–801. Bibcode:1994PNAS...91.6795C. doi:10.1073/pnas.91.15.6795. PMC 44285. PMID 8041699. Co-Extra research on chloroplast transformation NCBI full chloroplast genome

Sodium azide is an inorganic compound with the formula NaN3. This colorless salt is the gas-forming component in some car airbag systems. It is used for the preparation of other azide compounds. It is highly soluble in water and is acutely poisonous.

Sources: en.wikipedia.org

Frequently asked questions

What is SR9009?

SR9009 is a synthetic research compound that activates the REV-ERBα and REV-ERBβ nuclear receptors. It is not an approved drug and has no established human therapeutic use. Most published biological data come from cell and rodent studies.

Is SR9009 a SARM?

No. SR9009 is frequently mislabeled as a SARM in online discussions, but it does not target androgen receptors. Its known mechanism involves REV-ERB nuclear receptors and circadian-metabolic gene regulation.

What human data exist for SR9009?

Human clinical data are very limited. There is no approved human use, and safety and efficacy in people are not established. Most evidence comes from preclinical models, so effects observed in animals may not apply to humans.

How is SR9009 measured in samples?

The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.

Network